Letter to the EditorAcute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation
Section snippets
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
Disclosures
Azeem Latib: Consultant and Proctor for Direct Flow Medical.
Antonio Colombo: Minor shareholder of Direct Flow Medical.
References (4)
- et al.
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial)
Am. J. Cardiol.
(2014) Left ventricular assistant device Impella 2.5 usage for patients undergoing high-risk PCI
Catheter. Cardiovasc. Interv.
(2012)
There are more references available in the full text version of this article.
Cited by (1)
Transcatheter aortic valve implantation in the young
2016, International Journal of Cardiology
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.